ROIV – roivant sciences ltd. (US:NASDAQ)

News

Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at Guggenheim.
Roivant Sciences (ROIV) Valuation Check After Strong Share Price Momentum [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com